Countries Hong Kong
Hong Kong Approves Eli Lilly’s Mounjaro® as First Dual-Receptor Agonist for Obesity and Type 2 Diabetes
Adults taking Mounjaro in a clinical trial lost on average 48 lb. at the highest dose1,2 Mounjaro delivered superior A1C reductions versus all comparato...
October 28, 2024 | News
Everest Medicines’ VELSIPITY® Approved for Ulcerative Colitis in Greater Bay Area Hospitals under "Hong Kong and Macau Medicine Connect" Policy
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
October 25, 2024 | News
Antengene’s XPOVIO® Gains Third Approval in South Korea for Multiple Myeloma Treatment
This approval for XPOVIO® for the treatment of patients with multiple myeloma (MM) marks the third approved indication of the drug in South...
October 18, 2024 | News
Tencent Invests US$30 Million in Hong Kong’s Insighta, Valuing the Early Cancer Detection Company at US$200 Million
Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, announced that Tencent has made a strategic US$30 million&n...
October 16, 2024 | News
Akeso Biopharma Secures $250 Million in Share Placement to Accelerate Global Clinical Trials
Expediting International Clinical Trials for Pivotal Products Key Participants Include International Long-Term and Healthcare Funds Akeso Biopharma annou...
October 14, 2024 | News
Evonik Launches Global Competence Network to Advance Cell Culture-Based Therapies
First point of contact for partners seeking to manufacture cell culture-based therapies more efficiently Draws on multidisciplinary team of experts Dri...
October 03, 2024 | News
GenEditBio Secures Strategic Investment from Gobi Partners GBA to Advance Precision Genome Editing
GenEditBio Limited ("GenEditBio"), a biotech company co-founded by Prof. ZHENG Zongli from the City University of Hong Kong that focuses on pre...
October 01, 2024 | News
Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
The Hong Kong Breast Cancer Registry (HKBCR), run by the Hong Kong Breast Cancer Foundation (HKBCF), launched its 16th annual research report&nbs...
September 30, 2024 | News
MASSPHOTON and Sino Innovation Lab Launch World’s First Medical-Grade UVC LED Air Sterilizer
The experience of the COVID-19 pandemic has heightened global awareness of air quality and indoor environmental safety like never before. MASSPHOTON a...
September 12, 2024 | News
HKBU’s Centre for Chinese Herbal Medicine Drug Development Receives Approval for Clinical Trial of Novel Ulcerative Colitis Drug
Centre for Chinese Herbal Medicine Drug Development (CDD) at Hong Kong Baptist University (HKBU) has achieved a significant milestone in dev...
September 05, 2024 | News
HKBU Research Identifies Phosphocholine as a Potential Therapy for PM2.5-Related Lung Damage
A research team led by Hong Kong Baptist University (HKBU) has discovered that phosphocholine, an important component in the body's metabolism, c...
August 28, 2024 | News
STADA Expands APAC Consumer Healthcare Portfolio with Acquisition of Nizoral Cream from Janssen
well as the trademark rights (TM) in Hong Kong, Australia, Indonesia, Malaysia, New Zealand and Singapore This transaction continues the successful acqu...
August 21, 2024 | News
STADA Expands APAC Consumer Healthcare Portfolio with Acquisition of Nizoral Cream from Janssen
well as the trademark rights (TM) in Hong Kong, Australia, Indonesia, Malaysia, New Zealand and Singapore This transaction continues the successful acqu...
August 20, 2024 | News
Akeso’s Ivonescimab Granted Priority Review by China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC
Akeso, Inc. announced that the National Center for Drug Evaluation of the State Drug Administration of the People's Republic of China (NMPA CDE) ...
August 15, 2024 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
